HYBRID EVENT:You can Participate either IN-PERSON or virtually through ZOOM from your home/work.
4th International
VACCINE CONGRESS (IVC 2026)
Jul 06 - 07, 2026 at Rome, Italy (Hybrid Event)
HYBRID EVENT:You can Participate either IN-PERSON or virtually through ZOOM from your home/work.
Vaccine Congress 2026 invites researchers, scientists, healthcare professionals, and policymakers to join us in Rome, Italy, on July 06–07, 2026, for a dynamic two-day hybrid event centered around the theme:
“Vaccine Research, Development, and Delivery: Towards a Healthier Future.” This global platform brings together experts from academia, industry, and government to share the latest breakthroughs in vaccine development, immunization strategies, delivery technologies, and public health policy. The congress will feature plenary talks, keynote sessions, panel discussions, and oral/poster presentations from leading voices in vaccinology.
Why Attend?
Target Audience:
Vaccine Researchers & Developers, Immunologists & Microbiologists, Public Health Experts & Epidemiologists, Biotech & Pharmaceutical Professionals, Healthcare Providers & Clinicians, Regulatory Agencies & Policy Makers, Students & Early-Career Scientists.
Why Rome?
Hosted in the timeless city of Rome, where ancient history meets modern innovation, Vaccine Congress 2026 offers more than just a scientific gathering—it delivers a truly immersive experience. As a global capital of art, culture, and academia, Rome provides an inspiring backdrop for exploring the future of vaccines.
With its rich scientific program, stellar keynote lineup, and hybrid flexibility, Vaccine Congress-2026 is the ideal platform to advance your research, learn from global leaders, and forge lasting collaborations.
See you in Rome—on-site or online!
Do not hesitate and click the "Register" button on the top of the screen to register for attending the IVC-2026.
For further information, please contact Dr. Ryan Cooper, ryan_cooper@vaccine-
Jenner Institute, University of Oxford, United Kingdom
Responsible EU Affairs at Cittadinanzattiva, Italy
Londrina State University, Spain
U.S. Food and Drug Administration , USA
University of Maryland, Baltimore, USA
University fo Calgaray, Canada
FluPal Consultancy, Dutch Influenza Foundation, Netherlands
University of São Paulo - USP, Brazil
University of KwaZulu-Natal, Westville, Durban, South Africa
Virginia Tech, USA
Máxima Medical Center, The Netherlands
Babraham Institute, Cambridge, UK, UK
University of South Florida, USA
Univercity of Copenhagen, Denmark
Zhengzhou University, China
Texas A&M University, USA
GlaxoSmithKline, Italy
Greenwich School, USA
University of Southern Denmark, Denmark
Nagasaki University, Japan
Zydus Lifesciences, India
Quigley BioPharma LLC, USA
University of Texas Medical Branch, USA
Duke University , USA
IAVI, USA
University CEU, Spain
Xavier University of Louisiana, USA
Link University, Italy
University of Massachusetts Chan Medical School, USA
KU LEuven, Belgium
Universidad Simón Bolívar, Colombia
UKHSA, UK
Nunez Community College, USA
Don t Miss This Amazing Conference And Opportunities
Thank you, Ryan! I enjoyed the conference.
Thanks for organizing the nice meeting
Thank you so much, I thoroughly enjoyed the conference and appreciate the invitation to speak
Dear Mr. Cooper, thank You for giving me the opportunity to contribute to Your congress in Prague. The meeting was interesting, it was a pleasure to attend!
It was a great meeting
We really enjoyed the conference and Prague very much and a massive thank you to you all for giving us the opportunity to share our research at this prestigious conference .
I enjoyed the Vaccine Congress- it was great to interact with researchers working across different aspects of health sector
It was very interesting to get a lot of new insights